Amgen nears deal for Onyx

Amgen Inc., based in Thousand Oaks, may be close to an agreement to acquire Onyx Pharmaceuticals Inc., almost two months after being turned down by the South San Francisco company.
Reed Saxon / Associated Press
Copyright © 2016, Los Angeles Times
59°